Tactile Systems Technology, Inc. Common Stock (TCMD) Stock
Key stats
- Market cap
- $607.75M
- Price / Earnings ratio
- 25.0x
- EPS (TTM)
- $1.04
- Volume
- Loading
- 52-week high
- $37.77
- 52-week low
- $20.53
Source: third-party data provider, as of November 13, 2026
Compare with TCMD
Recent news

Tactile Systems: 3 Key Takeaways for Long-Term Investors
Tactile Systems: 3 Key Takeaways for Long-Term Investors
TCMD

What Tactile Systems Technology (TCMD) Said on Its Q3 Earnings Call
What Tactile Systems Technology (TCMD) Said on Its Q3 Earnings Call
TCMD

Tactile Systems Technology (TCMD) Q3 Earnings Surpass Estimates
Tactile Systems Technology (TCMD) Q3 Earnings Surpass Estimates
TCMD

Tactile Medical's Spending Outpaces Sales: Rapid Earnings Reaction
Tactile Medical's Spending Outpaces Sales: Rapid Earnings Reaction
TCMD
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 68.03
- MACD 12/26/9
- 1.02
- EMA 9 of MACD
- 0.68
- MACD histogram
- 0.34
- SMA 50
- $23.17
- Price above SMA 50
- EMA 50
- $24.14
- Price above EMA 50
- SMA 200
- $25.71
- Price above SMA 200
- EMA 200
- $25.50
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Tactile Systems: 3 Key Takeaways for Long-Term Investors
Tactile Systems: 3 Key Takeaways for Long-Term Investors
TCMD

What Tactile Systems Technology (TCMD) Said on Its Q3 Earnings Call
What Tactile Systems Technology (TCMD) Said on Its Q3 Earnings Call
TCMD

Tactile Systems Technology (TCMD) Q3 Earnings Surpass Estimates
Tactile Systems Technology (TCMD) Q3 Earnings Surpass Estimates
TCMD

Tactile Medical's Spending Outpaces Sales: Rapid Earnings Reaction
Tactile Medical's Spending Outpaces Sales: Rapid Earnings Reaction
TCMD

Tactile Systems Technology Q2 Earnings Call Highlights
Tactile Systems Technology Q2 Earnings Call Highlights
TCMD

Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates
Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates
TCMD

Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?
Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?
TCMD

Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
TCMD

Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
TCMD

Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
TCMD
News tone: automated (AI) classification of the article's content, not a price prediction.
About Tactile Systems Technology, Inc. Common Stock
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Sheri Louise Dodd | CEO, President & Director | 1966 |
| Ms. Elaine M. Birkemeyer | Chief Financial Officer | 1975 |
| Ms. Kristie T. Burns | Senior Vice President of Business Development | 1972 |
| Ben Amel | Chief Information Officer | — |
| Ms. Sunday J. Hoy Esq. | VP of Regulatory Affairs & Chief Compliance Officer | — |
| Aaron R. Snodgrass | Senior Vice President of Sales | — |
| Mr. Nicolaus B. Wilson | Senior Vice President of Marketing & Market Access | — |
| Janelle M. Strop | Chief Human Resource Officer | — |
| Dr. Antonios P. Gasparis F.A.C.S., M.D. | Chief Medical Officer & Member of Vascular Strategic Advisory Board | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 68.03
- MACD 12/26/9
- 1.02
- EMA 9 of MACD
- 0.68
- MACD histogram
- 0.34
- SMA 50
- $23.17
- Price above SMA 50
- EMA 50
- $24.14
- Price above EMA 50
- SMA 200
- $25.71
- Price above SMA 200
- EMA 200
- $25.50
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $31.00
- Average
- $31.00
- High
- $31.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.2 | -11.4 | +7.5 | +24.2 | -8.1 | -22.8 | +0.2 | +6.1 | +18.6 |



